Medizinische Universität Graz Austria/Österreich - Forschungsportal - Medical University of Graz

Logo MUG-Forschungsportal

Gewählte Publikation:

SHR Neuro Krebs Kardio Lipid Stoffw Microb

Szkandera, J; Kiesslich, T; Haybaeck, J; Gerger, A; Pichler, M.
Hedgehog signaling pathway in ovarian cancer.
Int J Mol Sci. 2013; 14(1):1179-1196 Doi: 10.3390/ijms14011179 [OPEN ACCESS]
Web of Science PubMed PUBMED Central FullText FullText_MUG


Führende Autor*innen der Med Uni Graz
Pichler Martin
Szkandera Joanna
Co-Autor*innen der Med Uni Graz
Gerger Armin
Haybäck Johannes

Dimensions Citations:

Plum Analytics:

Scite (citation analytics):

Despite advances in surgical and chemotherapeutic treatment options, less than 50% of patients with advanced-stage ovarian cancer survive five years after initial diagnosis. In this regard, novel treatment approaches are warranted utilizing molecularly targeted therapies directed against particular components of specific signaling pathways which are required for tumor development and progression. One molecular pathway of interest is the hedgehog (Hh) signaling pathway. Activation of the Hh pathway has been observed in several cancer types, including ovarian cancer. This review highlights the crucial role of Hh signaling in the development and progression of ovarian cancer and might lead to a better understanding of the Hh signaling in ovarian tumorigenesis, thus encouraging the investigation of novel targeted therapies.
Find related publications in this database (using NLM MeSH Indexing)
Animals -
Cell Transformation, Neoplastic - drug effects
Disease Progression -
Female -
Hedgehog Proteins - antagonists & inhibitors
Humans -
Models, Biological -
Molecular Targeted Therapy - methods
Ovarian Neoplasms - drug therapy
Signal Transduction -

Find related publications in this database (Keywords)
Hedgehog pathway
ovarian cancer
targeted therapy
© Med Uni Graz Impressum